Search results for "Ntic"

showing 10 items of 6004 documents

Lipid subclasses profiles and oxidative stress in aggressive periodontitis before and after treatment

2015

Background and Objective: Associations between dyslipidaemia, oxidative stress and periodontitis have emerged in recent years. However, there is a lack of studies investigating these associations in aggressive periodontitis (AgP) cases. The aim of this study was to investigate the lipid and oxidative stress profiles in patients with AgP, and to relate them to clinical variables and interleukin (IL)-6 genetic variants. Material and Methods: Twelve non-smoking Caucasian patients with AgP selected based on their IL6 haplotypes underwent periodontal non-surgical and surgical treatment. Peripheral blood samples taken at baseline and at six different time-points after treatment were processed to …

AdultMalemedicine.medical_specialtyAdolescentEuropean Continental Ancestry GroupLongitudinal Studiemedicine.disease_causeWhite Peoplechemistry.chemical_compoundYoung AdultGeneticInternal medicinemedicineHaplotypeAggressive periodontitisHumansLongitudinal StudiesPeriodontitismedicine.diagnostic_testCholesterolbusiness.industryInterleukin-6PeriodontitiOxidative Stress.BiomarkerLipidmedicine.diseaseLipidsAggressive PeriodontitiOxidative StressEndocrinologyTreatment OutcomechemistryAggressive PeriodontitisHaplotypesPeriodonticsOxidative strelipids (amino acids peptides and proteins)FemaleMetabolic syndromebusinessLipid profileDyslipidemiaOxidative stressBiomarkersLipoproteinHuman
researchProduct

Relationship between Patient Discomfort, Appliance Acceptance and Compliance in Orthodontic Therapy

2000

Orthodontic treatment is occasionally a discomfort to patients, due to pain or functional restrictions. In this context, several retrospectively planned studies were performed in the 1980s, but correlations between different aspects of patient discomfort were not investigated. The present study aimed at examining and structuring the psychogenic dimensions of patient discomfort. Furthermore, the impact of the patient's attitude on the intensity of discomfort was to be evaluated in addition to the influences of appliance therapy. The study was performed with 67 patients aged from 9 to 32 years. Prior to insertion of a new appliance, psychogenic scales reflecting their attitude towards orthodo…

AdultMalemedicine.medical_specialtyAdolescentmedia_common.quotation_subjectOrthodonticsContext (language use)Orthodontics CorrectiveCompliance (psychology)Orthodontic AppliancesAttitude towards treatmentHumansPsychogenic diseaseMedicineChildPatient compliancePain MeasurementRetrospective Studiesmedia_commonbusiness.industryRetrospective cohort studyPatient Acceptance of Health CareFeelingOral and maxillofacial surgeryPhysical therapyPatient ComplianceFemaleOral SurgerybusinessAttitude to HealthJournal of Orofacial Orthopedics / Fortschritte der Kieferorthopädie
researchProduct

Deferment of Objective Assessment of Deep Vein Thrombosis and Pulmonary Embolism Without Increased Risk of Thrombosis

2004

Background: Treatment of patients with suspected deep vein thrombosis (DVT) or pulmonary embolism (PE) is problematic if diagnostic imaging is not immediately available. Pretest clinical probability (PCP) and D-dimer assessment can be used to identify patients for whom empirical protective anticoagulation is indicated. To evaluate whether PCP and D-dimer assessment, together with the use of low-molecular-weight heparins (LMWHs), allow objective appraisal of DVT and PE to be deferred for up to 72 hours, patients with suspected DVT and PE were prospectively examined. Methods: Patients identified with a high PCP or a moderate PCP with positive D-dimer test results received a protective full-do…

AdultMalemedicine.medical_specialtyAdolescentmedicine.drug_classDeep veinLow molecular weight heparinFibrin Fibrinogen Degradation ProductsD-dimerInternal MedicinemedicineHumansRisk factoranticoagulationAgedAged 80 and overVenous ThrombosisPatientVascular diseasebusiness.industrylow molecular weight heparinAnticoagulantdeep vein thrombosisuspected PEHeparin Low-Molecular-WeightMiddle Agedmedicine.diseaseThrombosisSurgeryPulmonary embolismmedicine.anatomical_structureD dimerFemalePulmonary EmbolismbusinessAlgorithmsFollow-Up StudiesArchives of Internal Medicine
researchProduct

Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study.

2012

Summary.  Background:  Little information is available on the long-term clinical outcome of cerebral vein thrombosis (CVT). Objectives and methods:  In an international, retrospective cohort study, we assessed the long-term rates of mortality, residual disability and recurrent venous thromboembolism (VTE) in a cohort of patients with a first CVT episode. Results:  Seven hundred and six patients (73.7% females) with CVT were included. Patients were followed for a total of 3171 patient-years. Median follow-up was 40 months (range 6, 297 months). At the end of follow-up, 20 patients had died (2.8%). The outcome was generally good: 89.1% of patients had a complete recovery (modified Rankin Scor…

AdultMalemedicine.medical_specialtyAnticoagulant treatment; Cerebral vein thrombosis; Mortality; Recurrence; Adult; Cerebral Veins; Cohort Studies; Female; Humans; Male; Middle Aged; Recurrence; ThrombosisCohort StudiesAnticoagulant treatment; Cerebral vein thrombosis; Mortality; RecurrenceRecurrenceInternal medicinemedicineRisk of mortalityHumansMED/41 - ANESTESIOLOGIAMortalitybusiness.industryIncidence (epidemiology)Cerebral Vein thrombosiHazard ratioCerebral VeinRetrospective cohort studyThrombosisHematologyMiddle Agedmedicine.diseaseThrombosisCerebral VeinsConfidence intervalSurgerycerebral vein thrombosisSettore MED/15 - MALATTIE DEL SANGUEThrombosiCohortFemaleAnticoagulant treatmentCohort StudiebusinessHumanCohort studyJournal of thrombosis and haemostasis : JTH
researchProduct

Low intestinal cholesterol absorption is associated with a reduced efficacy of phytosterol esters as hypolipemic agents in patients with metabolic sy…

2010

Summary Background & aims Phytosterols (PS) lower LDLc, but their effect on metabolic syndrome (MetS) remains unknown. We evaluated whether low-fat milk enriched with PS improves cardiovascular risk factors in these patients. Methods A randomised parallel trial employing 24 moderate-hypercholesterolaemic MetS patients and consisting of two 3-month intervention phases. After a 3-month healthy diet, patients were divided into two intervention groups: diet (n = 10) and diet + PS (n = 14) (2 g/day). A control group of 24 moderate-hypercholesterolaemic patients without MetS (matched in age and BMI) underwent the same procedure. Results Neither dietary intervention nor enrichment of PS induced an…

AdultMalemedicine.medical_specialtyApolipoprotein BHomocysteineLipoproteinsHypercholesterolemiaPopulationCritical Care and Intensive Care MedicineSeverity of Illness IndexCholesterol Dietarychemistry.chemical_compoundRisk FactorsInternal medicinemedicineHumanseducationHypolipidemic AgentsMetabolic Syndromeeducation.field_of_studyNutrition and Dieteticsmedicine.diagnostic_testbiologybusiness.industryAnticholesteremic AgentsPhytosterolsMiddle Agedmedicine.diseaseSitosterolsCholesterolEndocrinologyIntestinal AbsorptionchemistryCardiovascular DiseasesSpainDietary SupplementsIntestinal cholesterol absorptionbiology.proteinFemaleMetabolic syndromebusinessLipid profileBody mass indexLipoproteinClinical Nutrition
researchProduct

Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targ…

2006

BACKGROUND: Despite the prognostic value of metabolic syndrome for predicting cardiovascular events, few trials have investigated the effects of statin therapy on cardiovascular morbidity and mortality in patients with the metabolic syndrome. Our post hoc analysis of the Treating to New Targets (TNT) study assessed whether intensive lowering of low-density lipoprotein cholesterol with high-dose atorvastatin therapy results in cardiovascular benefits for patients with both coronary heart disease and the metabolic syndrome. METHODS: The TNT study was a prospective, double blind, parallel-group trial done at 256 sites in 14 countries between April, 1998, and August, 2004, with a median follow-…

AdultMalemedicine.medical_specialtyAtorvastatinCoronary Diseaselaw.inventionDiabetes Complicationschemistry.chemical_compoundDouble-Blind MethodRandomized controlled trialRisk FactorslawInternal medicineDiabetes mellitusAtorvastatinmedicineHumansPyrrolesMyocardial infarctionStrokeAgedMetabolic SyndromeDose-Response Relationship Drugbusiness.industryCholesterolAnticholesteremic AgentsHazard ratioCholesterol LDLGeneral MedicineMiddle Agedmedicine.diseaseSurgerychemistryCardiovascular DiseasesHeptanoic AcidsCardiologyFemaleMetabolic syndromebusinessmedicine.drug
researchProduct

A case of atypical sporadic hemiplegic migraine associated with PFO and hypoplasia of vertebro-basilar system.

2009

We describe the case of a patient with atypical hemiplegic migraine and associated basilar symptoms, where a large patent foramen ovale (PFO) and hypoplasia of basilar artery were found. The longer period of 4-year remission of the headache attacks was coincident with the percutaneous PFO closure. When 5 years after, hemiplegic migraine attacks relapsed, with more relevant basilar symptoms, a mild re-opening of PFO was found. The atypical presentation of attacks with basilar symptoms and prolonged hemiplegia does not strictly fit the diagnostic criteria of ICHD-II.

AdultMalemedicine.medical_specialtyAuraMigraine with AuraClinical NeurologyForamen Ovale PatentHemiplegiaCase ReportNeurological disorderHemiplegic migraineRecurrencePFOmedicine.arteryBasilar arteryVertebrobasilar InsufficiencyMedicineHumansCardiac Surgical ProceduresBasilar type migrainebusiness.industryBasilar-Type MigraineAnticoagulantsBrainGeneral Medicinemedicine.diseaseMagnetic Resonance ImagingHypoplasiaMigraine with auraSurgeryAnesthesiology and Pain MedicineTreatment OutcomeVertebro-basilar system hypoplasiaMigraineBasilar ArteryPatent foramen ovalecardiovascular systemNeurology (clinical)sense organsmedicine.symptombusinessTomography X-Ray ComputedMagnetic Resonance AngiographyThe journal of headache and pain
researchProduct

Reward anticipation revisited- evidence from an fMRI study in euthymic bipolar I patients and healthy first-degree relatives.

2017

Abstract Background Symptomatic phases in bipolar disorder (BD) are hypothesized to result from a hypersensitive behavioral activation system (BAS) being sensitive to potential rewards. However, studies on the neuronal underpinnings of reward anticipation in BD are scarce with contradictory findings and possibly confounded by effects of dopaminergic medication, necessitating further research on dysfunctional motivation in BD. Moreover, its role as vulnerability marker for BD is unclear. Methods Functional imaging was conducted in 16 euthymic BD-I patients free from dopaminergic medication and 19 healthy first-degree relatives using a monetary incentive delay task and compared to parallelize…

AdultMalemedicine.medical_specialtyBipolar DisorderGyrus Cinguli03 medical and health sciences0302 clinical medicineRewardmedicineHumansFamilyBipolar disorderFirst-degree relativesPsychiatryAnterior cingulate cortexMotivationVentral striatumDopaminergicBehavioral activationmedicine.diseaseAnticipationMagnetic Resonance Imaging030227 psychiatryFunctional imagingPsychiatry and Mental healthClinical Psychologymedicine.anatomical_structureFemalePsychologypsychological phenomena and processes030217 neurology & neurosurgeryClinical psychologyJournal of affective disorders
researchProduct

Clinical evaluation of nanocrystalline hydroxyapatite paste in the treatment of human periodontal bony defects--a randomized controlled clinical tria…

2008

The aim of this study was to compare the clinical outcome of intrabony periodontal defects following treatment with a novel nanocrystalline hydroxyapatite (NHA) paste to open flap debridement.Twenty-eight subjects, each displaying one intrabony defect with probing depth (PD)or =6 mm and radiographic evidence of an intraosseous componentor =3 mm participated in the present study. Subjects were allocated randomly to treatment with NHA paste (test group) or open flap debridement (control group). At baseline and at 6 months after surgery, the following clinical parameters were recorded by a masked examiner: plaque index, gingival index, PD, clinical attachment level (CAL), and gingival recessio…

AdultMalemedicine.medical_specialtyBone Regenerationmedicine.medical_treatmentRadiographyAlveolar Bone LossDentistryStatistics Nonparametriclaw.inventionRandomized controlled triallawmedicineHumansBone regenerationPeriodontitisAgedPeriodontitisbusiness.industryOpen flap debridementMiddle Agedmedicine.diseaseChronic periodontitisSurgeryClinical trialDurapatiteTreatment OutcomeDebridementDebridement (dental)Bone SubstitutesPeriodonticsNanoparticlesFemalePeriodontal IndexbusinessJournal of periodontology
researchProduct

Patients requiring interruption of long-term oral anticoagulant therapy: the use of fixed sub-therapeutic doses of low-molecular weight heparin.

2009

Introduction: We tested the efficacy and safety of fixed doses of Low-Molecular Weight Heparin (LMWH) in patients requiring interruption of Vitamin-k Antagonist (VKA) because of invasive procedures Methodology: Pre-operatively, patients discontinued VKA 5 +/- 1days; in those at low-risk for thrombosis, LMWH was given at a prophylactic dosage of 3.800 U.I. (nadroparin) or 4.000 U.I. (enoxaparin) anti-FXa once daily the night before the procedure. In patients at high-risk for thrombosis, LMWH was started early after VKA cessation and given at fixed sub-therapeutic doses (3.800 or 4.000 UI anti-FXa twice daily) until surgery. Post-operatively, LMWH was reinitiated 12 hours after procedure whil…

AdultMalemedicine.medical_specialtyBridging low molecular weight heparinTime FactorsVitamin Kmedicine.drug_classLow molecular weight heparinAdministration OralPostoperative HemorrhageRisk AssessmentDrug Administration ScheduleSettore MED/15 - Malattie Del SangueRisk FactorsThromboembolismmedicineHumansProspective StudiesEnoxaparinProspective cohort studyAgedAged 80 and overbusiness.industryIncidence (epidemiology)WarfarinAnticoagulantsNadroparinHematologyHeparinHeparin Low-Molecular-WeightMiddle Agedmedicine.diseaseThrombosisConfidence intervalSurgeryLow Molecular Weight Heparin Fixed doses Chronic oral anticoagulation perioperative bridgingAnesthesiaSurgical Procedures OperativeNadroparinFeasibility StudiesFemaleWarfarinbusinessmedicine.drugFactor Xa Inhibitors
researchProduct